Trial Comparing 3 and 4 Week Regimen of Gemcitabine and Cisplatin in Patients With Lung Cancer
Status:
Completed
Trial end date:
2005-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate response rate of the 3 week versus 4 week treatment
of gemcitabine with cisplatin as the first line treatment for non-small cell lung cancer
patients in China.